What does the past generation of failure in Alzheimer’s R&D look like in one slide?

Just how bad is it in the Alzheimer’s R&D arena?

IQVIA just put together something of an impressionist piece on the slew of trial failures recorded over the years (below).

Except for one pop in 2014 — for a dementia drug, Namzaric — there’s nothing by way of an FDA approval going back to 2002, 17 years of failure and disaster, with Eli Lilly, Pfizer, J&J and others going over the amyloid beta cliff.